Karachi: GlaxoSmithKline Pakistan Limited has announced the resignation of Ms. Ana Paula De Freitas Passos from her position as a Non-Executive Director on the company’s Board of Directors. This change will take effect from May 31, 2026, as stated in a report dated June 1, 2026.
The pharmaceutical giant, known for its substantial market footprint, has not yet appointed a successor to fill the vacancy left by Ms. Passos. The company plans to notify the Pakistan Stock Exchange of any new appointments to the Board in due course.
According to information available from the Pakistan Stock Exchange (PSX), the departure of Ms. Passos marks a notable shift in the composition of GlaxoSmithKline Pakistan’s leadership. The company has communicated this update to the TRE Certificate Holders of the Exchange.
This resignation comes as the company continues to navigate its strategic objectives within the designated market category, focusing on maintaining robust governance practices.